Prostate International

Papers
(The median citation count of Prostate International is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
A review of social determinants of prostate cancer risk, stage, and survival60
Prostate diseases and microbiome in the prostate, gut, and urine26
Increased tumor-associated macrophages in the prostate cancer microenvironment predicted patients’ survival and responses to androgen deprivation therapies in Indonesian patients cohort26
Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer24
Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer19
Clinical implications of genomic evaluations for prostate cancer risk stratification, screening, and treatment: a narrative review16
Prostatic artery embolization versus transurethral resection of the prostate in management of benign prostatic hyperplasia15
Impact of surgically maximized versus native membranous urethral length on 30-day and long-term pad-free continence after robot-assisted radical prostatectomy14
What is the ideal number of biopsy cores per lesion in targeted prostate biopsy?13
Radiation-induced haemorrhagic cystitis after prostate cancer radiotherapy: factors associated to hospitalization and treatment strategies13
Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients13
Changes in diagnosis rate and treatment trends of benign prostatic hyperplasia in Korea: A nationwide population-based cohort study13
Efficacy and safety of apalutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a subgroup analysis of a randomized, double-blind, placebo-controlled, Phase-3 study13
Survival and quality of life outcomes of high-intensity focused ultrasound treatment of localized prostate cancer11
Impact of positive surgical margin on biochemical recurrence in localized prostate cancer11
Open simple prostatectomy and robotic simple prostatectomy for large benign prostatic hyperplasia: Comparison of safety and efficacy11
A systematic review of outcomes after thermal and nonthermal partial prostate ablation11
Impact of the evolving United States Preventative Services Task Force policy statements on incidence and distribution of prostate cancer over 15 years in a statewide cancer registry10
Rebiopsy rate after transperineal or transrectal prostate biopsy10
Changing trends in robot-assisted radical prostatectomy: Inverse stage migration—A retrospective analysis10
Biparametric versus multiparametric magnetic resonance imaging of the prostate: detection of clinically significant cancer in a perfect match group9
Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures9
Micro-Ultrasound: a way to bring imaging for prostate cancer back to urology9
RNA-seq profile of African American men with a clinically localized prostate cancer8
Topical antiseptic at time of transrectal ultrasound prostate biopsy is associated with fewer severe clinical infections and improves antibiotic stewardship8
A study on prostate movement and dosimetric variation because of bladder and rectum volumes changes during the course of image-guided radiotherapy in prostate cancer8
Risk factors associated with pain in fusion prostate biopsy8
Comparison of a combined regimen of fosfomycin and ciprofloxacin with ciprofloxacin alone as antimicrobial prophylaxis for transrectal prostate biopsy in the era of high fluoroquinolone-resistant rect8
Robotic-assisted simple prostatectomy versus holmium laser enucleation of the prostate for large benign prostatic hyperplasia: A single-center preliminary study in Korea8
Comparing open and robotic salvage radical prostatectomy after radiotherapy: predictors and outcomes7
Initial experience of single-port robot-assisted radical prostatectomy: A single surgeon's experience with technique description7
Measurement of autophagy flux in benign prostatic hyperplasia in vitro7
Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy7
Improvement of the symptoms of lower urinary tract and sexual dysfunction with tadalafil and solifenacin after the treatment of benign prostatic hyperplasia with dutasteride7
Minimal invasive management of bladder neck contracture using Allium round posterior stent: the long-term results7
Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer7
The significance of the visible tumor on preoperative magnetic resonance imaging in localized prostate cancer6
Factors affecting biochemical recurrence of prostate cancer after radical prostatectomy in patients with positive and negative surgical margin6
Multiparametric magnetic resonance imaging and clinical variables: Which is the best combination to predict reclassification in active surveillance patients?6
Non-infectious complications following transrectal prostate needle biopsy – Outcomes from over 8000 procedures5
Expression of hsv1-miR-H18 and hsv2-miR-H9 as a field defect marker for detecting prostate cancer5
Revision of CHAARTED and LATITUDE criteria among Japanese de novo metastatic prostate cancer patients5
Enhanced inhibition of tumor growth using TRAIL-overexpressing adipose-derived stem cells in combination with the chemotherapeutic agent CPT-11 in castration-resistant prostate cancer5
Comparison of three questionnaire forms used in the diagnosis of lower urinary tract symptoms: A prospective study5
Comparative efficacy and safety profile of 4 vs 8 mg of silodosin once daily usage in patients with benign prostatic hyperplasia–related lower urinary tract symptoms divided into subgroups according t5
The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy in clinically significant prostate cancer detection in patients with biopsy-naïve men according to PSA levels: A prop5
Diagnostic yield of multiparametric MRI for local recurrence at biochemical recurrence after radical prostatectomy5
Robotic-assisted radical prostatectomy: learning curves and outcomes from an Australian perspective5
Does music from noise-canceling headphones have a beneficial effect on men undergoing transrectal ultrasound-guided prostate biopsy?4
Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with castration-resistant prostate cancer4
Olaparib outcomes in metastatic castration-resistant prostate cancer: First real-world experience in safety and efficacy from the Chinese mainland4
Combined α-methylacyl-CoA racemase inhibition and docetaxel treatment reduce cell proliferation and decrease expression of heat shock protein 27 in androgen receptor-variant-7–positive prostate cancer4
Lifestyle habits to prevent the development of benign prostatic hyperplasia: Analysis of Japanese nationwide datasets4
Androgen deprivation therapy may reduce the risk of primary open-angle glaucoma in patients with prostate cancer: a nationwide population-based cohort study4
Extended versus standard pelvic lymph node dissection yields no difference in 3-year biochemical recurrence rates4
Is antibiotic prophylaxis still mandatory for transperineal prostate biopsy? Results of a comparative study4
DNA methylation biomarkers distinguishing early-stage prostate cancer from benign prostatic hyperplasia4
Possibilities and limitations of using low biomass samples for urologic disease and microbiome research4
How many cores should be taken from each region of interest when performing a targeted transrectal prostate biopsy?4
Usefulness of grayscale values measuring hypoechoic lesions for predicting prostate cancer: An experimental pilot study4
Dr. Answer AI for prostate cancer: Intention to use, expected effects, performance, and concerns of urologists4
Prognostic impact of dose reduction in androgen receptor pathway inhibitors for castration-resistant prostate cancer4
Clinical experience with active surveillance protocol using regular magnetic resonance imaging instead of regular repeat biopsy for monitoring: A study at a high-volume center in Korea4
Patient age as a predictive factor in biochemical recurrence following brachytherapy: Oncological outcomes at a single center4
Prostate-specific antigen kinetics contributes to decision making for biopsy referral: the predictive implication for PSA retest in patients with elevated PSA levels4
Effectiveness of magnetic resonance imaging–targeted biopsy for detection of prostate cancer in comparison with systematic biopsy in our countries with low prevalence of prostate cancer: our first exp4
Efficacy and safety of cabazitaxel therapy in elderly (≥75 years) patients with castration-resistant prostate cancer: A multiinstitutional study4
Retzius-sparing robotic prostatectomy is associated with higher positive surgical margin rate in anterior tumors, but not in posterior tumors, compared to conventional anterior robotic prostatectomy4
A meta-analysis on the use of radiotherapy after prostatectomy: adjuvant versus early salvage radiation4
Temporal changes of PIRADS scoring by radiologists and correlation to radical prostatectomy pathological outcomes4
Predictors of readmission and impact of same-day discharge in holmium laser enucleation of the prostate4
Association between predictors of progression of benign prostatic hyperplasia and moderate-to-severe prostatitis-like symptoms: A propensity score–matched analysis4
Clinical use of expanded prostate cancer index composite-based health-related quality of life outcomes after robot-assisted radical prostatectomy for localized prostate cancer3
Conditional biochemical recurrence-free survival after radical prostatectomy in patients with high-risk prostate cancer3
Comparing effects of alpha-blocker management on acute urinary retention secondary to benign prostatic hyperplasia: A systematic review and network meta-analysis3
Expanding armamentarium in advanced prostate cancer management: are all novel antiandrogens the same?3
Effects of leuprolide acetate on the quality of life of patients with prostate cancer: A prospective longitudinal cohort study3
A novel biguanide derivative, IM176, induces prostate cancer cell death by modulating the AMPK-mTOR and androgen receptor signaling pathways3
Irreversible electroporation for prostate cancer using PSMA PET-CT3
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer3
Robotic-assisted simple prostatectomy after prostatic arterial embolization for large benign prostate hyperplasia: Initial experience3
Diagnostic accuracy of F-18-Fluorocholine PET/CT and multiparametric MRI for prostate cancer3
Current treatment patterns within 1 year after prostate cancer diagnosis in Korean patients over 75 years old: a retrospective multicenter study3
Androgen deprivation therapy and risk of cognitive dysfunction in men with prostate cancer: is there a possible link?3
Intraductal carcinoma of the prostate in an Irish prostate cancer patient cohort—an aggressive pathology and a strong familial link3
Artificial intelligence in urologic oncology: the actual clinical practice results of IBM Watson for Oncology in South Korea3
Active surveillance versus nonradical treatment for low-risk men with prostate cancer: a review3
Impact of preoperative factors on recovery of continence after artificial urinary sphincter implantation in postprostatectomy incontinence3
Diagnostic value of integrated 18F-PSMA-1007 PET/MRI compared with that of biparametric MRI for the detection of prostate cancer3
Prostate cancer trajectory-map: clinical decision support system for prognosis management of radical prostatectomy3
0.13160920143127